These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7562020)

  • 1. Changing pattern of relapse in osteosarcoma of the extremities treated with adjuvant and neoadjuvant chemotherapy.
    Bacci G; Ruggieri P; Picci P; Briccoli A; Ferraro A; Ferrari S; Tienghi A; Iantorno D; Campanacci M
    J Chemother; 1995 Jun; 7(3):230-9. PubMed ID: 7562020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern of relapse in patients with osteosarcoma of the extremities treated with neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Perin S; Forni C; Fabbri N; Salduca N; Versari M; Smith KV
    Eur J Cancer; 2001 Jan; 37(1):32-8. PubMed ID: 11165127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities: the recent experience at the Rizzoli Institute.
    Bacci G; Picci P; Ferrari S; Avella M; Prever BA; Ruggieri P; Casadei R; Lari S; Monti C; Cazzola A
    Cancer Treat Res; 1993; 62():299-308. PubMed ID: 7682090
    [No Abstract]   [Full Text] [Related]  

  • 4. Limb-sparing in patients with non-metastatic high-grade osteosarcoma.
    Samardziski M; Zafiroski G; Tolevska C; Zafirova-Ivanovska B; Kostadinova-Kunovska S; Kalicanin-Markovska M
    J BUON; 2009; 14(1):63-9. PubMed ID: 19373949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
    Berend KR; Pietrobon R; Moore JO; Dibernardo L; Harrelson JM; Scully SP
    J Surg Oncol; 2001 Nov; 78(3):162-70. PubMed ID: 11745799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
    Yu W; Tang L; Lin F; Yao Y; Shen Z
    Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy for non-metastatic osteosarcoma of the extremities in two New Zealand cancer centres.
    Jameson MB; Evans BD; Gray DH; Forgeson GV; Allan SG; Humm G; Thomson J; Thompson PI; Harvey VJ
    Aust N Z J Med; 1995 Jun; 25(3):224-9. PubMed ID: 7487690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.
    Hong S; Shin SJ; Jung M; Jeong J; Lee YJ; Shin KH; Roh JK; Rha SY
    Oncology; 2011; 80(1-2):107-17. PubMed ID: 21677455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary chemotherapy and delayed surgery (neoadjuvant chemotherapy) for osteosarcoma of the extremities. The Istituto Rizzoli Experience in 127 patients treated preoperatively with intravenous methotrexate (high versus moderate doses) and intraarterial cisplatin.
    Bacci G; Picci P; Ruggieri P; Mercuri M; Avella M; Capanna R; Brach Del Prever A; Mancini A; Gherlinzoni F; Padovani G
    Cancer; 1990 Jun; 65(11):2539-53. PubMed ID: 2337871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
    Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
    Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy for nonmetastatic osteosarcoma of the extremities.
    Bacci G; Picci P; Pignatti G; De Cristofaro R; Dallari D; Avella M; Manfrini M; Marangolo M; Ferruzzi A; Mercuri M
    Clin Orthop Relat Res; 1991 Sep; (270):87-98. PubMed ID: 1884564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment and outcome of recurrent osteosarcoma: experience at Rizzoli in 235 patients initially treated with neoadjuvant chemotherapy.
    Bacci G; Briccoli A; Longhi A; Ferrari S; Mercuri M; Faggioli F; Versari M; Picci P
    Acta Oncol; 2005; 44(7):748-55. PubMed ID: 16227167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution.
    Bacci G; Forni C; Longhi A; Ferrari S; Mercuri M; Bertoni F; Serra M; Briccoli A; Balladelli A; Picci P
    J Surg Oncol; 2007 Aug; 96(2):118-23. PubMed ID: 17577221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: the Rizzoli Institute experience.
    Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):908-12. PubMed ID: 19131777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases.
    Bacci G; Ferrari S; Ruggieri P; Biagini R; Fabbri N; Campanacci L; Bacchini P; Longhi A; Forni C; Bertoni F
    Acta Orthop Scand; 2001 Apr; 72(2):167-72. PubMed ID: 11372948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen.
    Bacci G; Ferrari S; Bertoni F; Mercuri M; Forni C; Sottili S; Gasbarrini A; Tienghi A; Cesari M; Campanacci M
    J Chemother; 1997 Aug; 9(4):293-9. PubMed ID: 9269611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan.
    Kudawara I; Aoki Y; Ueda T; Araki N; Naka N; Nakanishi H; Matsumine A; Ieguchi M; Mori S; Myoui A; Kuratsu S; Hashimoto N; Yoshikawa H
    J Chemother; 2013 Feb; 25(1):41-8. PubMed ID: 23433444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors for local recurrence in osteosarcoma: 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Mercuri M; Bertoni F; Picci P; Manfrini M; Gasbarrini A; Forni C; Cesari M; Campanacci M
    Acta Orthop Scand; 1998 Jun; 69(3):230-6. PubMed ID: 9703394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant chemotherapy for the treatment of osteosarcoma of the extremities: a comparison of results obtained in single-institution and multicenter trials.
    Bacci G; Mercuri M; Longhi A; Setola E; Gozzi E; Forni C
    Chir Organi Mov; 2004; 89(4):283-92. PubMed ID: 16048049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.